stroke (CVS) mortality is three times higher in Hungary, and twice as high in Slovakia. We hypothesized that this is due to better treatment and control of hypertension in Austria.
Introduction
Since the fall of communism in 1989 in Central and Eastern Europe, increasing attention is being paid to the poor state of health in postcommunist societies. The worst health indicators are found in areas of the former Soviet Union, where the probability of early mortality before 65 years is twice that of Western Europe. 1 In Central European countries, the overall health situation is somewhat better, albeit there are significant differences between countries. Life expectancy at birth is 75 years in the Czech Republic, somewhat less in the Slovak Republic (73 years) and worse in Hungary (71 years). 2, 3 We were particularly interested in comparing data between Austria, the Slovak Republic and Hungary. Before World War I, these neighbouring countries were part of the Austria-Hungarian monarchy. At the end of World War II, the political system changed in these countries. Austria remained a free country with a market economy that has enjoyed economic prosperity in contrast to Hungary and Slovakia. This is reflected in the differences between the gross national income per capita in these three countries, where Austrian incomes are six to eight times higher than in Slovakia or Hungary (Table 1) .
The standard death rate comparing all causes of death for all ages per 100 000 population per year shows that Hungarian mortality rates are about 70% higher than Austrian rates, while mortality rates in the Slovak Republic are about 50% higher ( Table 2 ). The mortality rates from cerebrovascular stroke (CVS) mortality are of particular interest. In Slovakia and even more in Hungary, CVS mortality is significantly higher than that of Austria or Canada (Figure 1 ).
Since hypertension is the most important risk factor for CVS 4, 5 and successful treatment of hypertension results in significant reduction of these events, 6 we hypothesized that the differences seen between these three countries are due either to differences in the prevalence of hypertension, or as a result of better treatment of hypertension in Austria compared to Hungary and Slovakia.
To gain a better insight into this problem, we decided to carry out a pilot study in these three countries. The primary objective was to establish the prevalence of hypertension and treatment status in each of these countries. The secondary objectives were to assess the awareness and the level of control of hypertension, and to test the feasibility of international comparative studies in this part of the world. Comparative studies of blood pressure levels in different populations attempted in the past have been difficult to evaluate because of large interand intraobserver error when using standard mercury manometers or random zero instruments. The availability of a new Canadian blood pressure measuring instrument, the Bp-TRUt, made it possible to avoid measurement errors and to obtain reliable BP values. 7 
Methods
In all the three countries, the studies were carried out in 'blue collar' work settings. In Austria, respondents were recruited from a large bakery in Vienna, from labourers in Vienna Harbour and from auxiliary staff from the Vienna General Hospital (orderlies, cleaners, etc). In Hungary, respondents were recruited from employees of the 'Pick' salami factory in Szeged. The Slovak study was carried out in the city of Sala, in a factory for producing chemicals and fertilizers (Duslo). Respondents were invited to participate in examinations through announcements by the management, unions and posters that explained the purpose of the investigation. Ethical approval was obtained from the respective universities in the three countries. The investigation was carried out by a team of physicians and nurses. The respective teams in each country visited the worksites and held a special hypertension detection clinic. Upon arrival, the respondents were interviewed using a short, standardized questionnaire (see Appendix 1); these contained identical questions in all of the participating countries, translated into the Hungarian, Slovak and German languages.
The subjects were asked not to eat or smoke for at least 30 min before their examination. Prior to the blood pressure measurement, they rested quietly for a minimum of 5 min. The participant's right arm was held at the level of the heart. The Bp-TRUt blood pressure measuring instrument was used to determine blood pressure. This instrument measured the systolic and diastolic blood pressure (SBP and DBP, respectively) six times at 1-min intervals, discarded the first value, and calculated the average SBP and DBP based on the remaining five consecutive measurements. The instrument also recorded the heart rate. All data were sent to the University of Ottawa Heart Institute and entered into a database. Standard parametric and nonparametric tests were applied using SAS and Excel statistical programs.
Hypertensives were classified as those respondents who had an SBP X140 mmHg and/or DBP X90 mmHg, or those who were taking antihypertensive medication, regardless of their blood pressure level. 'Controlled' hypertensives were classified as those treated with antihypertensive drugs and with SBPo140 mmHg and DBPo90 mmHg. Respondents who were identified as newly discovered hypertensives were referred to a physician for further treatment, as were those respondents who were treated but whose blood pressure was not controlled.
Results
In Austria, 372 respondents were screened in total (323 male, 48 female and one missing gender data); in Hungary, 1021 in total (600 male, 412 female and nine missing gender data); and in Slovakia, 1190 (751 male, 439 female). Given the small number of women screened in Austria, the comparative analyses were performed only on males. The mean ages (Table 3) ; of these, 73% in Austria were newly diagnosed as were 45% in Hungary and 67% in Slovakia. Of those aged 39 years or less, 19% were hypertensive and of those aged 40 years or more, 50% were hypertensive. There are significant differences (Po0.05) in the SBP and DBP between the three countries (Table 4) . Of those who were classified as hypertensive and who were on antihypertensive medication, hypertension control was achieved in only 9.7% in Austria, 14.9% in Hungary and 5.3% in Slovakia (Table 5 ).
Our results indicate that although Hungary has the highest level of CV mortality, it also had the best level of hypertension control (14.9%), demonstrated by mean SBP and DBP below 140/90 mmHg in the treated group (Table 4 ). Slovakia had the lowest level of control at 5.3% and the highest mean SBP and DBP at 152.2/95.8 mmHg in the treated group. Despite having the lowest CV mortality, Austria also had a low level of hypertension control with the mean SDP and DBP at 141.2/93.1 mmHg in the treated group (Table 4) .
Discussion
This study set out to establish the prevalence of hypertension and treatment status in work sites in Austria, Hungary and Slovakia, and to test the feasibility of international comparative studies in this part of the world. We have documented that it is possible to implement such studies with relative ease and fast acquisition of valuable data. However, the primary objective of this study was to investigate whether the relatively low CVS mortality in Austria, as compared to Slovakia and Hungary, is a result of better awareness and treatment of hypertension in Austria. The work site settings were chosen with regard not only to the feasibility of the study but also because we expected that in low socioeconomic groups the lack of awareness and treatment would be more accentuated. The fact that the socioeconomic gradient is inversely related to health status is amply documented, 8 as is the fact that treatment of hypertension results in a significant reduction of stroke mortality and morbidity. 9 There were no significant differences in the control of hypertension between the three countries; in fact, the level of hypertension control was comparable to statistics in Canada. 10 The striking differences in morbidity and mortality of postcommunist societies have been studied in the past decade by many authors. Kesteloot 13 concluded that, while the Hungarian population is more obese and nutrition is characterized by a high fat and meat content, the traditional cardiovascular disease risk factors are not strikingly different between the two countries. Our findings are in line with these observations in that the prevalence and control of hypertension, which is a significant cardiovascular disease risk factor, do not differ greatly between countries with a relatively low cardiovascular mortality (Austria) and countries with a high cardiovascular mortality (Hungary and Slovakia). Thus, our study indicates that neither the awareness of hypertension nor the intensity of treatment of hypertension provides an explanation for the differences in the CVS mortality between Austria, Hungary and Slovakia. It is evident that determinants such as nutrition, psychosocial stress and other as yet unidentified factors may play a role.
In summary, despite dramatic differences in cerebrovascular stroke mortality between Austria, Hungary and Slovakia, our study establishes that this gradient is not due to better treatment and control of hypertension in Austria, and highlights the need for further research to determine the cause of this mortality gradient in Eastern Europe.
